Phenanthrene

Phenanthrene

SCHEMBL21751231

c1ccc(Pc2ccccc2)cc1.c1ccc2c(c1)ccc1ccccc12

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
HSD17B10 Q99714 4/20 0.63
CYP2A6 P11509 3/20 0.63
TSHR P16473 2/20 0.63
TDP1 Q9NUW8 1/20 0.63
HPRT1 P00492 3/20 0.57
HIF1A Q16665 1/20 0.52
CYP1B1 Q16678 1/20 0.52
PAX8 Q06710 1/20 0.46
CYP3A4 P08684 1/20 0.41
CYP1A2 P05177 3/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
HPGD P15428 2/20 0.40
WDR5 P61964 1/20 0.40
THRB P10828 1/20 0.40
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5260942 0.83 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL29125567 0.83 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP2A6TSHRTDP1
Naphthalene SCHEMBL27602315 0.83 CYP2A6 (0.53) ALDH1A1HSD17B10CYP2A6TSHRTDP1
Phenanthrene SCHEMBL201780 0.83 ALDH1A1 (0.92) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL6391262 0.83 TDP1 (0.41) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL184292 0.83 TDP1 (0.41) ALDH1A1HSD17B10CYP2A6TSHRTDP1
Phenanthrene SCHEMBL2321409 0.80 ALDH1A1 (0.86) ALDH1A1HSD17B10CYP2A6TSHRTDP1
Phenanthrene SCHEMBL28634294 0.80 HSD17B10 (0.86) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL2824075 0.80 HSD17B10 (0.44) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL4377802 0.80 ALDH1A1 (0.85) ALDH1A1HSD17B10CYP2A6TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240050469-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2024-02-15 US claimed
US-11779598-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates THE FLORIDA INTERNATIONAL UNIVERISTY BOARD OF TRUSTEES (US) 2023-10-10 US claimed
US-20220047628-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2022-02-17 US claimed
US-10828327-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2020-11-10 US claimed
US-20200061110-A1 SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2020-02-27 US claimed
US-20240050469-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2024-02-15 US disclosed
US-11779598-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates THE FLORIDA INTERNATIONAL UNIVERISTY BOARD OF TRUSTEES (US) 2023-10-10 US disclosed
US-20220047628-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2022-02-17 US disclosed
US-11160829-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2021-11-02 US disclosed
US-20200376025-A1 SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2020-12-03 US disclosed
US-10828327-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2020-11-10 US disclosed
US-20200061110-A1 SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10828327-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-11160829-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-20220047628-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-20240050469-A1 Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-20200376025-A1 SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-20200061110-A1 SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885
US-11779598-B2 Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates POLR1C, ZC3HAV1, HELZ ALDH1A1 3502/4885HSD17B10 4245/4885CYP2A6 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.